貝瑞基因(000710.SZ):子公司擬與李巍設立合資公司
格隆匯8月8日丨貝瑞基因(000710.SZ)公佈,根據北京貝瑞和康生物技術有限公司(簡稱“貝瑞和康”)業務規模發展及運營的需要,成都市貝瑞和康基因技術股份有限公司全資子公司貝瑞和康擬與自然人李巍先生在河南省鄭州市投資設立控股子公司,子公司擬註冊名稱爲河南壹元童康基因科技有限公司(簡稱“壹元童康”“合資公司”)(最終名稱以市場監督管理部門覈定登記爲準),註冊資本爲100萬元人民幣。其中,貝瑞和康以自有資金認繳出資60萬元,持股比例爲60%;自然人李巍先生以自有資金認繳出資40萬元,持股比例爲40%。
本次子公司對外投資設立合資公司,首期註冊資本100萬元,主要用於場地租金和初期人員費用,合資公司的產品及其相關服務(包含基因測序和AI智能體服務等),主要通過向成都市貝瑞和康基因技術股份有限公司及其下屬主體採購獲得。合資公司將根據業務進展情況,通過註冊資本增資等方式,擴充合資公司經營資金。如合資公司未來經營情況符合各方預期,預計註冊資本不低於5,000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.